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Background: Hyperactivation of nuclear factor-κB (NF-κB) is associated with various types of tumors. This study
investigated the susceptibility of the rs4648068 A/G genotype in the intron region of NFKB1 to gastric cancer and
the association of this polymorphism with clinicopathologic variables in gastric cancer patients.
Methods: A hospital-based case–control study of 248 gastric cancer patients and 192 control individuals was
conducted in Fudan University Shanghai Cancer Center (Shanghai, China). Single nucleotide polymorphism (SNP)
rs4648068 genotype in NFKB1 from blood samples of a total of 440 people was analyzed by polymerase chain
reaction-based genotyping.
Results: The frequencies of the AA, AG, and GG genotypes of the rs4648068 polymorphism were 31.5%, 47.2%, and
21.3% in the gastric cancer patients and 29.7%, 59.9%, and 10.4% in the control individuals, respectively. We found that
the GG genotype was associated with a significantly increased risk of gastric cancer (P=0.042). Furthermore, among the
gastric cancer cases, the rs4648068 GG genotype was associated with high clinical stage (AOR=2.27, 95%
CI: 1.11- 4.66), lymph node involvement (AOR=2.90, 95% CI = 1.40- 6.03) and serosa invasion (AOR= 2.78, 95%
CI = 1.34- 5.75). However, rs4648068 genotypes were not associated with tumor differentiation in gastric cancer patients.
Conclusions: Homozygous rs4648068 GG was associated with an increased risk of gastric cancer, especially for the
lymph node status and serosa invasion in Han Chinese population.
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Gastric cancer (GC) is the second leading cause of
cancer-related deaths and the fourth most frequent can-
cer in the world [1]. Generally, GC mortality is ranked
the highest in Eastern Asia (China, Japan), Eastern Eur-
ope, and South America compared with other cancerous
tumors, whereas GC mortality is ranked the lowest in
North America and most parts of Africa. The etiology of
this cancer is multifactorial, involving both genetic and
environmental risk factors. To clarify the genetic back-
ground of the gastric cancer, it is necessary to* Correspondence: jykca@sina.com
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reproduction in any medium, provided the orspecifically identify the genetic factors such as single nu-
cleotide polymorphisms (SNPs).
Nuclear factor kappa B (NF-κB) is a family of structur-
ally related eukaryotic transcription factors that are per-
sistently active in the pathogenesis of numerous
malignancies, including prostate [2], breast [3,4], colo-
rectal [5], pancreatic [6], oral [7], and gastric carcinoma
cancer [8]. The NF-κB family contains five members in
mammals: NFKB1 encoding p50, NFKB2 encoding p52,
RELA encoding p65, REL encoding c-Rel, and RELB en-
coding Rel-B. The most common dimer is the p65/p50
heterodimer. The human NFKB1 gene is located at
chromosome 4q24. Several groups have shown that
there is a relationship between gastric cancer and the
polymorphisms of NFKB1 promoter regions [9,10], and
local tumor growth and lymph node spread in gastric
cancer have also been proven to be associated with N-This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Primers used for quantitative real-time PCR
assays
SNP Primer Primer sequence
rs12509517 Upstream fwd 5’ ACG TAC TAG GAA GTC CTA C 3’
Upstream fmut 5’ ACG TAC TAG GAA GTC CTA G 3’
Downstream rev 5’ GGT TAT GCA GGA TGT TAC CAT TGG 3’
rs4648065 Upstream fwd 5’ TAA CGT ATG CA A CAG GAA C 3’
Upstream fmut 5’ TAA CGT ATG CA A CAG GAA T3’
Downstream rev 5’ GAT ATC TTT CTG CAC CTA GGA CTG3’
rs4648068 Upstream fwd 5”TAA TTG TTA GAG ATT CCA A 3’
Upstream fmut 5’ TAA TTG TTA GAG ATT CCA G3’
Downstream rev 5’ ACA ATG TTA GAT TTT ACC ATG ATT3’
rs4648037 Upstream fwd 5’ TAA CAC CTT AAA AGG GTG C3’
Upstream fmut 5’ TAA CAC CTT AAA AGG GTG T3’
Downstream rev 5’ ATC ATT TAA TCA GTT GCC ATT GGG3’
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[11-13]. This study investigated the possible association
between the SNP polymorphisms of NFKB1 and suscep-
tibility to gastric cancer and its tumor behavior.
We first screened SNPs throughout the entire NFKB1
gene locus and selected 4 SNP sites from 99 SNP sites
that were in linkage disequilibrium (LD) in the Hapmap
CHB (Han Chinese in Beijing, China) data: rs12509517
and rs4648068, which are in LD with the tagging SNP
rs230539 (r2> 0.8), and rs4648065 and rs4648037
(r2< 0.8). The genetic associations of the SNPs were
examined by comparing the genotypes of 30 unrelated
gastric cancer patients with those of 30 healthy controls
in a small-scale genotyping study. Then, we conducted a
large-scale case–control study on the Han Chinese
population to investigate the association of the
rs4648068 polymorphism with gastric cancer and clini-
copathologic variables of gastric cancer patients using
quantitative real-time PCR (qRT-PCR).
Methods
Patients and tissue samples
A total of 440 unrelated Chinese participants including
248 patients with gastric cancer and 192 unaffected con-
trol participants were recruited with written informed
consent, and all human samples were collected with the
approval of the Ethics Committee at the Fudan Univer-
sity Cancer Hospital. All subjects were part of the Han
population in China. Age, gender, and other clinico-
pathologic characteristics were evaluated by reviewing
medical charts and pathologic records. There were no
differences in age and gender between gastric cancer
patients and the control participants (P> 0.05).
Sample preparation and NFKB1 genotyping
DNA samples were prepared and genotyped as described
previously [14,15]. Briefly, genomic DNA was extracted
from peripheral blood samples of each study subject
using the TIANamp Blood DNA Kit (Tiangen Biotech,
China). Four NFKB1 SNPs (rs12509517, rs4648068,
rs4648065, rs4648037) were genotyped by SYBR allelic
discrimination, and their corresponding qRT-PCR spe-
cific primers are listed in Table 1. PCRs were run in a 20
μL reaction solution containing 30 ng of template DNA
and 10 μL SYBR Premix Ex Taq (Takara, Japan) accord-
ing to the manufacturer’s instructions. PCR was per-
formed at 95°C for 10 min and 40 cycles at 95°C for 30 s
and 58°C for 30 s. The samples were amplified, read, and
analyzed in OpticonW Fluorescence Temperature Cycler
(MJ Research, Canada).
Statistical analysis
The Haploview 4.2 software (http://www.broad.mit.edu/
mpg) was used to draw a LD map for 99 SNPs (withminor allele frequency ≥ 0.05) located in the NFKB1 re-
gion according to the genotype data for Han Chinese
populations of the International HapMap Project (Hap-
Map Data Rel 27 Phase II + III, Feb09, on NCBI B36 as-
sembly, dbSNP b126) and to measure the pairwise LD
values between SNPs. The SNPs that were tagged by
these 4 SNPs with r2> 0.6 can be illustrated with the
LD map [16].
Adjusted odds ratio (AOR) and associated 95% confi-
dence interval (CI) were calculated using multivariate lo-
gistic regression analysis. The comparison of age and
gender were performed by student t- test and Pearson chi-
square test, respectively, where P< 0.05 indicated a sig-
nificant difference. All of the association calculations were
conducted with SPSS (version 13.0; SPSS Inc., Chicago).
Results
Gastric cancer susceptibility association of 4 NFKB1 SNPs
To identify the genetic variations in NFKB1 that are asso-
ciated with a susceptibility to gastric cancer, we examined
the NFKB1 region and selected 4 SNP sites from 99 SNP
sites in LD of NFKB1: rs12509517 and rs4648068, which
are in LD with the tagging SNP rs230539 (r2> 0.8), and
rs4648065 and rs4648037 (r2< 0.8). According to the
genotype data for the CHB by the International HapMap
Project, the values of LD between these 4 SNPs and other
ungenotyped polymorphisms in the HapMap database are
shown in Additional file: 1 Figure S1, in which rs4648037,
rs4648065, rs4648068, and rs12509517 are located at sites
142, 168, 169, and 188, respectively. As illustrated in this
Additional file: 1 Figure S1, all of the ungenotyped poly-
morphisms were tagged by these 4 tag SNPs with r2> 0.6.
A small-scale qRT-PCR genotyping study was con-
ducted to examine the genetic association of these SNPs
with gastric cancer. Because polymorphisms in intron or
exon regions are all reported to regulate transcription and
Table 3 Genotype distribution and allelic frequencies of
NFKB1 rs4648068 polymorphism in gastric cancer
patients and control subjects
Gastric Cancer Controls AOR (95%CI) Δ P valueΔ
Cases (n) 248 192 / /
Age 57 ± 11* 53 ± 15 / /
Gender (M/F) 160/88** 119/73 / /
Genotype
GG(%) 53(21.3)# 20(10.4) 1.92(1.02-3.60) 0.042
AG(%) 117(47.2) 115(59.9) 0.75(0.48-1.16) 0.195
AA (%) 78(31.5) 57(29.7) 1.00
Allelic frequencies
G(%) 223(45.0) 155(40.4) 1.13(0.99-1.36) 0.198
A(%) 273(55.0) 229(59.6) 1.00
* and **, P> 0.05 and minor allele frequency (MAF) = 0.346; M, male; F, female;
#, P= 0.042 (GG is risk factor); Δ, multivariate logistic regression adjusted by
age and gender.
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(rs12509517, rs4648068) and 2 exon SNPs (rs4648065,
rs4648037) out of the SNP pool for our analysis.
Comparison of 30 gastric cancer patients and 30
healthy control individuals showed that only SNP
rs4648068 had a significant association with susceptibil-
ity to gastric cancer (P= 0.029), whereas the other 3
SNPs showed no association with susceptibility to gastric
cancer (Table 2). Of the individuals with gastric cancer,
33.3% had the GG genotype in rs4648068, compared
with 10% with the GG genotype in the healthy control
individuals. In contrast, the probability of AA alleles in
gastric cancer patients is 13.3% less than that in healthy
controls. Surprisingly, this SNP, rs4648068, is in the in-
tron region of the NFKB1 gene. Because there are many
previous reports on intronic SNPs that were associated
with the activity of protein expression [21], diseases [22],
or disorders [23] through gene regulation and transcript
processing [24], we conducted a large-scale study of
rs4648068.An NFKB1 polymorphism is associated with an increased
risk of gastric cancer
After the preliminary small-scale genotyping, we con-
ducted a large-scale genotyping study of rs4648068. Ana-
lysis of the rs4648068 genotype polymorphism showed aTable 2 Genotype distribution of 4 SNPs in gastric cancer










n % n %
rs12509517
GG 14 46.7 9 30.0 1.08(0.53-2.21) 0.601
CG 12 40.0 18 60.0 0.76(0.31-1.63) 0.420
CC 4 13.3 3 10.0 1.00
rs4648065
TT 6 20.0 3 10.0 1.73(0.83-4.12) 0.313
CT 8 26.7 3 10.0 1.62(0.99-2.69) 0.065
CC 16 53.3 24 80.0 1.00
rs4648068
GG 10 33.3 3 10.0 2.90(1.01-6.93) 0.029*
AG 16 53.4 17 56.7 1.68(0.62-4.01) 0.293
AA 4 13.3 10 33.3 1.00
rs4648037
TT 15 50.0 22 73.3 0.63(0.28-1.39) 0.193
CT 8 26.7 5 16.7 0.67(0.40-1.83) 0.390
CC 7 23.3 3 10.0 1.00
AOR, adjusted odds ratio, which was calculated using multivariate logistic
regression adjusted by age and gender; CI, confidence interval.significant difference between gastric cancer patients and
control individuals (Table 3). The rs4648068 GG genotype
was significantly more common in the gastric cancer
patients than in the control individuals (P= 0.042), which
further implied that homozygous GG was a genetic risk
factor for gastric cancer and agreed well with the results
of our preliminary small-scale genotyping study described
above. Results of stratified analyses by age, clinical stage,
tumor differentiation, lymph node status, and serosa inva-
sion with the NFKB1 rs4648068 A/G polymorphism vari-
ant genotypes and alleles are presented in Table 4.Association between NFKB1 rs4648068 polymorphism
and age/gender of gastric cancer patients
The role of the rs4648068 polymorphism in different age
groups and gender groups of gastric cancer patients was
evaluated. Because age and gender are reported to be
the 2 major risk factors of gastric cancer, and this disease
is reported to be more common in men over the age of
55 than in other groups [25-28], we divided the gastric
cancer patients into 2 age groups (age ≤ 55 and age> 55),
or groups that were divided by gender. However, the
associations of this polymorphism with age and gender
were not statistically significant.Association of NFKB1 rs4648068 polymorphism and
clinical stage of gastric cancer
We evaluated whether the association between the
rs4648068 polymorphism and gastric cancer was modi-
fied by the clinical stages of the cancer by dividing the
gastric cancer patients into 2 groups: clinical stages I + II
and clinical stages III + IV. The frequency of the GG
genotype in clinical stages III + IV was significantly
higher than that in clinical stages I + II (P= 0.025, AOR=
Table 4 Association between the genotype of the NFKB1 rs4648068 polymorphism and patient characteristics
N GG AOR (95%CI)Δ P valueΔ GA AOR (95%CI) Δ P valueΔ AA AOR (95%CI)Δ P valueΔ G A AOR (95%CI)* P value*
Clinical Stage
III + IV 128 33(25.8) 2.27(1.11 ~ 4.66) 0.025 62(48.4) 1.55(0.87 ~ 2.78) 0.139 33(25.8) - 128(50.0) 128(50.0) 1.86(1.22 ~ 2.82) 0.004
I + II 120 20(16.7) - 55(45.8) - 45(37.5) - 95(39.6) 145(60.4) -
Tumor differentiation
Poor 118 29(24.6) 1.34(0.66-2.70) 0.418 52(44.1) 0.89(0.50 ~ 1.58) 0.680 37(31.4) - 110(46.6) 126(53.4) 1.08(0.71 ~ 1.63) 0.729
Well & moderate 130 24(18.5) - 65(50.0) - 41(31.5) - 113(43.5) 147(56.5) -
Lymph node status
Positive 111 29(26.1) 2.90 (1.40 ~ 6.03) 0.004 59(53.2) 2.44(1.33-4.50) 0.004 23(20.7) - 117(52.7) 105(47.3) 2.67(1.72 ~ 4.13) 0.001
Negative 137 24(17.5) - 58(42.3) - 55(40.1) 106(38.7) 168(61.3) -
Serosa invasion
Positive 126 34(27.0) 2.78(1.34 ~ 5.75) 0.006 62(49.2) 1.74(0.97-3.13) 0.064 30(23.8) - 130(51.6) 122 (48.4) 2.17(1.42 ~ 3.31) 0.001
Negative 122 19(15.6) - 55(45.1) 48(39.3) - 93(38.1) 151 (61.9) -
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tween high clinical stage and the G allele (Table 4).
NFKB1 rs4648068 is associated with the survival of gastric
cancer patients
As indicated in Table 4, lymph node status and serosa in-
vasion were significantly associated with the survival of
gastric cancer patients. Stratified analyses by lymph node
status showed that patients carrying the G allele were
more likely than those carrying the A allele to have a posi-
tive lymph node status (52.7% versus 38.7%, P= 0.001).
Furthermore, there was a significant correlation between
the genotype and serosa invasion. The frequency of the
GG genotype in serosa invasion-positive patients was sig-
nificantly higher than that in serosa invasion-negative
patients (27.0% versus 15.6%, P=0.006). The frequency of
G carriers in serosa invasion-positive patients was also sig-
nificantly higher than that in serosa invasion-negative
patients (51.6% versus 38.1%, P=0.001, AOR=2.17, 95%
CI: 1.42- 3.31). However, rs4648068 genotypes were not
associated with the tumor differentiation in gastric cancer
patients (Table 4).
Discussion
NF-κB was reported to be a proinflammatory transcrip-
tion factor, which could bind the enhancer of the kappa
light chain of immunoglobulin and promote tumorigen-
esis [29,30]. The rs4648068 (A>G) polymorphism was
identified in a study of the analysis of variation in NFKB1
genes and expression levels of NF-κB regulated molecules,
and SNP rs4648068 was subsequently reported to be asso-
ciated with VCAM1 and LDL phenotypes [31,32].
Considering there is a relationship between gastric
cancer and the promoter region of NFKB1 [9,10] and
many reports also showed that the genetic variations in
introns might involve alternative gene regulation, tran-
script processing, or chromosomal rearrangements
[16,17,23,24], the association between the rs4648068
polymorphism in NFKB1 and gastric cancer has been
studied. Here, we found that the rs4648068 polymorph-
ism had a significantly different distribution in gastric
cancer patients and healthy control individuals in a pre-
liminary small-scale genotyping study (P= 0.029). There-
fore, we investigated the role of the NFKB1 rs4648068
polymorphism in gastric cancer susceptibility in the Han
Chinese population in a case–control study. The results
indicated that people with the homozygous GG alleles in
rs4648068 had a 2.65-fold increased risk of gastric can-
cer compared people carrying other rs4648068 alleles
(P= 0.042).
Surprisingly, although reports showed that age and
gender are the 2 major risk factors of gastric cancer, and
gastric cancer is reported to be more common in men
over the age of 55 than in other groups of individuals[25-28], our stratified analysis by age and gender did not
modify the association between rs4648068 and the risk
of gastric cancer. Lewander’s group [33] and Gao’s group
[34] have reported that the genetic polymorphisms have
the opposite effect in Swedish populations compared
with Chinese populations and in Asian populations com-
pared with Caucasian populations. Whether our results
are ethnically dependent requires further elucidation. In
addition, although the minor allele frequency (MAF) of
rs4648068 is high (0.346), this conclusion would be
more convincing if it can be replicated in another
cohort.
On the basis of our genetic association data in the Han
Chinese population, the SNP within an NFKB1 intron re-
gion (rs4648068) showed marginal significance. This sug-
gested that there might be correlation between NFKB1
genotypes and the gastric cancer clinicopathologic charac-
teristics such as lymph node status and serosa invasion be-
cause of the different associations that were observed for
the high-risk subsets and the low-risk subsets.
The SNP rs4648068 (A or G) resides in intron 11 of
NFKB1, occupying position 103,518,305 of chromosome
4. The predominant nucleotide at this position is A for
human, chimpanzee, and macaque, but G for orangutan,
mouse, and dog. There is no conserved trait at this pos-
ition in the genome of elephants, opossum, chicken, or
zebrafish, although the corresponding region is Nfkb in
these organisms. The percentages of the A and G alleles
in the Han Chinese ethic group in Beijing are 0.609 and
0.391 (www.Hapmap.org), respectively; our study in
Shanghai found that the percentages of the A and G
alleles are 0.551 and 0.449, respectively. The discrepancy
may result from geographic factors because the percen-
tages of A and G alleles in Han Chinese in Denver, Col-
orado, are also different from the above findings (A:
0.596; G: 0.404, data from www.Hapmap.org). To eluci-
date the potential functional role of SNP rs4648068, we
also performed a bioinformatic data mining study using
the UCSC genome browser (http://genome.ucsc.edu/cgi-
bin/hgTracks) and Encode databases. The region near
rs4648068 in intron 11 of NFKB1 exhibited increased
levels of H3K9me1 and H3K4me1 (the highest value of
H3K9me1 is 15, while the increase of the H3K4me1 level
is not as remarkable as that of H3K9me1). These tracks
displayed maps of chromatin state that were generated
by the Broad/MGH ENCODE group using chromatin
immunoprecipitation coupled with sequencing (ChIP-
seq). Chemical modifications (methylation for H3K9me1
and acetylation for H3K4me1) to the histone proteins
that are present in chromatin influence gene expression
by changing the accessibility of the chromatin to tran-
scription factors. The increased levels of chemo-
modification imply that rs4648408 may be located in a
regulatory element, such as an enhancer. Hence, the G
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enhancer, which may have an influence on disease in the
host.
In the present study, we observed that the frequency
of the G allele in clinical stages III + IV patients was sig-
nificantly higher than that in clinical stages I + II
patients, indicating that this polymorphism is associated
with high clinical stage (P= 0.025). On the other hand,
the stratified analysis by lymph node status showed that
patients with the GG genotype and G carriers were more
likely than those with the AA genotype and A carriers to
have a positive lymph node status (P= 0.004 and 0.001,
respectively), suggesting that this polymorphism might
contribute to the constitutive NF-κB activity in gastric
cancer.
Our investigations also demonstrated that the fre-
quency of the GG homozygous_genotype in serosa
invasion-positive patients was significantly higher than
that in serosa invasion-negative patients (P= 0.006).
Tumor invasion is regulated by numerous NF-κB target
gene products, including MMP-9, TIMP-1/2, PAL 2,
CXCR4, interleukin-8 (IL-8), and other chemokines
[29,35,36]. NF-κB plays an essential role in the migration
and the organ-specific homing of metastatic breast can-
cer cells [35,37].
Further study
In our future experiments, we plan to use a dual-
luciferase reporter assay in gastric cancer cell lines
(MKN28, SNU216, SNU16, SCG7901, and HGC-27) to
observe the LPS-induced luciferase expression level,
which correlates with the mRNA level, to explore
whether the mechanism of this association involves al-
ternative gene regulation and transcript processing.
Conclusions
In this study, we have shown that people who carry the
GG homozygous_genotype of the rs4648068 polymorph-
ism in the NFKB1 gene appear to be at increased risk
for developing gastric cancer. Furthermore, in gastric
cancer patients, the G allele is associated with high clin-
ical stage, positive lymph node status, and positive serosa
invasion.
Additional file
Additionaf file 1: Figure S1. LD map including 4 SNPs of the NFKB1
genomic region in the Han Chinese population. The rs4648037,
rs4648065, rs4648068, and rs12509517 SNPs are located at sites
142,168,169, and 188, respectively. The values of LD between these 4
SNPs (shown are r2 > 0.6) and other ungenotyped polymorphisms are
presented.
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